Hypodopaminergic and hypernoradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder - The spontaneously hypertensive rat

Behavioural Brain Research

Volumn 130, Issue 1-2, 2002, Pages 191-196

  Russell, Vivienne Ann ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Dopamine; Frontal cortex; Hyperactive; In vitro; Norepinephrine; Release

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; AUTORECEPTOR; DEXAMPHETAMINE; DOPAMINE; DOPAMINE RECEPTOR; NORADRENALIN;

ADRENERGIC ACTIVITY; ANIMAL MODEL; ANIMAL TISSUE; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; CONFERENCE PAPER; CONTROLLED STUDY; CYTOPLASM; DEPOLARIZATION; DOPAMINE RELEASE; DOPAMINERGIC ACTIVITY; DOPAMINERGIC NERVE CELL; ELECTROSTIMULATION; ESSENTIAL HYPERTENSION; EXCITATORY POSTSYNAPTIC POTENTIAL; GENETIC MODEL; HYPERACTIVITY; IMPULSIVENESS; INFORMATION; LIMBIC CORTEX; NONHUMAN; NORADRENALIN RELEASE; NORADRENERGIC SYSTEM; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; STRIATE CORTEX; SUBSTANTIA NIGRA;

ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; DOPAMINE; NOREPINEPHRINE; PREFRONTAL CORTEX; RATS; RATS, INBRED SHR; SYNAPTIC TRANSMISSION;

EID: 0037051147     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(01)00425-9     Document Type: Conference Paper

References (41)

1. Parallel organization of functionally segregated circuits linking basal ganglia and cortex
2. Catecholamine modulation of prefrontal cortical cognitive function
3. Evaluation of the spontaneously hypertensive rat as a model of attention deficit hyperactivity disorder: Acquisition and performance of the DRL-60s test
4. The nigrostriatal dopamine system and the development of hypertension in the spontaneously hypertensive rat
5. 3H]dopamine release from nucleus accumbens slices and monoamine levels in a rat model for attention-deficit hyperactivity disorder
6. DA transporter density in patients with attention deficit hyperactivity disorder
7. DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A [fluorine-18] fluorodopa positron emission tomographic study
8. 18F]DOPA accumulation in children with attention deficit hyperactivity disorder
9. The neurobiology of attention-defict hyperactivity disorder
10. Up-regulation of dopamine receptors in the brain of the spontaneously hypertensive rat: An autoradiographic analysis
11. Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: Effects of methylphenidate as measured by single photon emission computed tomography
12. Effect of the dopamine D2 receptor agonist quinpirole on the in vivo release of dopamine in the caudate nucleus of hypertensive rats
13. 14C]acetylcholine release from nucleus caudatus slices: Differences between spontaneously hypertensive rats and Wistar-Kyoto rats
14. Hemispheric processing and methylphenidate effects in attention-deficit hyperactivity disorder
15. Relationships bettween the prefrontal cortex and the basal ganglia in the rat: Physiology of the cortico-nigral circuits
16. A neuroanatomical and biochemical basis for attention-deficit disorder with hyperactivity in children; a defect in tonic adrenaline mediated inhibition of locus coeruleus stimulation
17. Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain
18. Deficient intracortical inhibition in drug-naïve children with attention-deficit hyperactivity disorder is enhanced by methylphenidate
19. D1 receptor in interneurons of macaque prefrontal cortex: Distribution and subcellular localization
20. Changes in catecholamine neuronal uptake and receptor binding in the brains of spontaneously hypertensive rats (SHR)
21. Airpuff startle stress elicited fos expression in brain cardiovascular areas of young SHR and WKY rats
22. Dextroamphetamine: Cognitive and behavioral effects in normal prepubertal boys
23. Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: Most antidepressants selectively block norepinephrine uptake
24. The nucleus accumbens motor-limbic interface of the spontaneously hypertensive rat as studied in vitro by the superfusion slice technique
25. Increased noradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder - The spontaneously hypertensive rat
26. Altered dopaminergic function in the prefrontal cortex, nucleus accumbens and caudate-putamen of an animal model of attention-deficit hyperactivity disorder - The spontaneously hypertensive rat
27. Impaired vesicular storage of dopamine in an animal model for attention-deficit hyperactivity disorder - The spontaneously hypertensive rat
28. 3H]dopamine from brain slices suggest impaired vesicular storage of dopamine in an animal model for attention-deficit hyperactivity disorder
29. Behavioural validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD)
30. Behavior of hypertensive and hyperactive rat strains: Hyperactivity is not unitarily determined
31. Frequent reward eliminates differences in activity between hyperkinetic rats and controls
32. The spontaneously hypertensive rat (SHR) as an animal model of childhood hyperactivity (ADHD): Changed reactivity to reinforcers and to psychomotor stimulants
33. Spontaneously hypertensive rats (SHR) as a putative animal model of childhood hyperkinesis: SHR behavior compared to four other rat strains
34. Attention deficit/hyperactivity disorder - From brain dysfunctions to behaviour
35. Vesicle neurotransmitter transporters: Pharmacology, biochemistry, and molecular analysis
36. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: A review and integration
37. Visual sustained attention in a child psychiatric population
38. Functional deficits in basal ganglia of children with attention-deficit hyperactivity disorder shown with functional magnetic resonance imaging relaxometry
39. Influence of the mesocortical/prefrontal dopamine neurons on their target cells
40. Norepinephrine release and neuropeptide Y in medulla oblongata of spontaneously hypertensive rats
41. Brain dopamine transporter in spontaneously hypertensive rats